Target intelligence / Profile preview

Cyclin-dependent kinase inhibitor 1A

Molecular classification
Cyclin-dependent kinase inhibitor, Tumor suppressor
01

Overview

Cyclin-dependent kinase inhibitor 1A (CDKN1A), also known as p21, Waf1, or Cip1, is a potent inhibitor of cyclin-dependent kinases (CDKs). It plays a crucial role in regulating cell cycle progression by binding to and inhibiting the activity of cyclin-CDK2 or -CDK4 complexes. This inhibition prevents phosphorylation of key substrates required for cell cycle progression from G1 to S phase. p21/CDKN1A is primarily regulated by the tumor suppressor protein p53. In response to DNA damage or other stress signals that activate p53, CDKN1A expression increases.

Other names
p21Waf1Cip1
02

Mechanism of action

CDKN1A inhibits cyclin-CDK complexes, leading to cell cycle arrest. It is primarily regulated by p53 in response to DNA damage or other stress signals.

03

Biological functions

Cell cycle regulationG1/S checkpoint controlDNA damage responseApoptosis regulationInhibition of cyclin-CDK complexes
04

Disease associations

Cancer
05

Safety considerations

Loss or dysfunction can compromise G1 checkpoint control and contribute to tumorigenesis.
06

Biomarkers

CDKN1A expression level (prognostic marker)

Beyond the preview

Go deeper on Cyclin-dependent kinase inhibitor 1A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-dependent kinase inhibitor 1A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call